Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry

[1]  E. Kieff,et al.  Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry , 2018, Nature Microbiology.

[2]  E. Song,et al.  Nonmuscle myosin heavy chain IIA mediates Epstein–Barr virus infection of nasopharyngeal epithelial cells , 2015, Proceedings of the National Academy of Sciences.

[3]  E. Kieff,et al.  Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells , 2015, Nature Communications.

[4]  Qiang Shu,et al.  From development to diseases: the role of 5hmC in brain. , 2014, Genomics.

[5]  R. Desrosiers,et al.  Binding of the Kaposi's Sarcoma-Associated Herpesvirus to the Ephrin Binding Surface of the EphA2 Receptor and Its Inhibition by a Small Molecule , 2014, Journal of Virology.

[6]  D. Xiao,et al.  EphA2 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells , 2014, Oncogene.

[7]  Feimeng Zheng,et al.  IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiation , 2014, Nature Communications.

[8]  P. Lieberman.  Epstein-Barr Virus Turns 50 , 2014, Science.

[9]  M. Rowe,et al.  Epstein Barr virus entry; kissing and conjugation. , 2014, Current opinion in virology.

[10]  S. Tracy,et al.  The pathogenesis of Epstein-Barr virus persistent infection. , 2013, Current opinion in virology.

[11]  G. Tsokos,et al.  Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor. , 2013, Cell reports.

[12]  R. Longnecker,et al.  Modulation of Epstein-Barr Virus Glycoprotein B (gB) Fusion Activity by the gB Cytoplasmic Tail Domain , 2013, mBio.

[13]  Chang-yun Yu,et al.  EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel. , 2012, Oncology letters.

[14]  Jin Chen,et al.  The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus , 2012, Nature Medicine.

[15]  B. Chandran,et al.  Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection , 2012, Proceedings of the National Academy of Sciences.

[16]  L. Hutt-Fletcher,et al.  Important but Differential Roles for Actin in Trafficking of Epstein-Barr Virus in B Cells and Epithelial Cells , 2011, Journal of Virology.

[17]  N. Cosford,et al.  A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors , 2011, Chemical biology & drug design.

[18]  L. Hutt-Fletcher,et al.  Fusion of Epstein-Barr Virus with Epithelial Cells Can Be Triggered by αvβ5 in Addition to αvβ6 and αvβ8, and Integrin Binding Triggers a Conformational Change in Glycoproteins gHgL , 2011, Journal of Virology.

[19]  D. Cheresh,et al.  αV integrins in angiogenesis and cancer. , 2011, Cold Spring Harbor perspectives in medicine.

[20]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[21]  L. Hutt-Fletcher,et al.  Fusion of epithelial cells by Epstein–Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8 , 2009, Proceedings of the National Academy of Sciences.

[22]  B. Chandran.  Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells , 2009, Journal of Virology.

[23]  Z. Shang,et al.  Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. , 2008, Oral oncology.

[24]  W. Debinski,et al.  The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting , 2008, Molecular Cancer Research.

[25]  D. Pehlivan,et al.  Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies. , 2008, Oncology reports.

[26]  Elena B Pasquale,et al.  Eph-Ephrin Bidirectional Signaling in Physiology and Disease , 2008, Cell.

[27]  L. Hutt-Fletcher.  Epstein-Barr Virus Entry , 2007, Journal of Virology.

[28]  E. Zabarovsky,et al.  TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. , 2006, Cancer research.

[29]  T. Jardetzky,et al.  Soluble Epstein-Barr Virus Glycoproteins gH, gL, and gp42 Form a 1:1:1 Stable Complex That Acts Like Soluble gp42 in B-Cell Fusion but Not in Epithelial Cell Fusion , 2006, Journal of Virology.

[30]  L. Hutt-Fletcher,et al.  Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells , 2006, Journal of Virology.

[31]  Yun-Fei Xia,et al.  Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. , 2006, Cancer research.

[32]  T. Langmann,et al.  Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. , 2004, Clinical chemistry.

[33]  D. Sheppard.  Functions of pulmonary epithelial integrins: from development to disease. , 2003, Physiological reviews.

[34]  C. Rüegg,et al.  Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis , 2003, Cellular and Molecular Life Sciences CMLS.

[35]  L. Hutt-Fletcher,et al.  Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus , 2002, Nature Medicine.

[36]  Qingxue Li,et al.  Epstein-Barr Virus Uses Different Complexes of Glycoproteins gH and gL To Infect B Lymphocytes and Epithelial Cells , 1998, Journal of Virology.

[37]  K. Aldape,et al.  Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. , 1995, Journal of cell science.

[38]  D. Pehlivan,et al.  Involvement of EphA 2 in head and neck squamous cell carcinoma : mRNA expression , loss of heterozygosity and immunohistochemical studies , 2008 .